Literature DB >> 11925614

A study of recombinant protective H.pylori antigens.

Zheng Jiang1, Xiao-Hong Tao, Ai-Long Huang, Pi-Long Wang.   

Abstract

AIM: To construct a recombinant vector which can express M (r)26000 outer membrane protein (OMP) from Helicobacter pylori (Hp), and to obtain the vaccine protecting against Hp infection and a diagnostic reagent kit quickly detecting Hp infection.
METHODS: The gene encoding the structural M(r)26000 outer membrane protein of Hp was amplified from Hp chromosomal DNA by PCR, and inserted in the prokaryotic expression vector pET32a (+), which was transformed into the Top10 E. coli strain. Recombinant vector was selected, identified and transformed into BL-21(DE3) E. coli strain. The recombinant fusion proteins were expressed. The antigenicity of recombinant protein was studied by ELISA or immunoblotting and immunized Balb/c mice.
RESULTS: The gene of M(r)26000 OMP was amplified to be 594 base pairs, 1.1% of the cloned genes was mutated and 1.51% of amino acid residues was changed, but there was homogeneity between them. The recombinant fusion protein encoded objective polypeptides of 198 amino acid residues, corresponding to calculated molecular masses of M (r)26000. The level of soluble expression products was about 38.96% of the total cell protein. After purification by Ni-NTA agarose resin columniation, the purity of objective protein became about 90%. The ELISA results showed that recombinant fusion protein could be recognized by patient serum infected with Hp and rabbit serum immunized with the recombinant protein. Furthermore,Balb/c mice immunized with the recombinant protein were protected against H.pylori infection.
CONCLUSION: M (r)26000 OMP may be a candidate vaccine preventing Hp infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11925614      PMCID: PMC4658373          DOI: 10.3748/wjg.v8.i2.308

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  Nucleic acid immunization: concepts and techniques associated with third generation vaccines.

Authors:  U A Hasan; A M Abai; D R Harper; B W Wren; W J Morrow
Journal:  J Immunol Methods       Date:  1999-10-29       Impact factor: 2.303

2.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

3.  Complete regression of primary gastric MALT-lymphoma after double eradication Helicobacter pylori therapy: role and importance of endoscopic ultrasonography.

Authors:  G Casella; C A Buda; R Maisano; M Schiavo; D Perego; V Baldini
Journal:  Anticancer Res       Date:  2001 Mar-Apr       Impact factor: 2.480

4.  Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.

Authors:  M Suganuma; M Kurusu; S Okabe; N Sueoka; M Yoshida; Y Wakatsuki; H Fujiki
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

Review 5.  Helicobacter pylori vaccine strategies--triggering a gut reaction.

Authors:  C Hatzifoti; B W Wren; W J Morrow
Journal:  Immunol Today       Date:  2000-12

6.  Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.

Authors:  P Ghiara; M Rossi; M Marchetti; A Di Tommaso; C Vindigni; F Ciampolini; A Covacci; J L Telford; M T De Magistris; M Pizza; R Rappuoli; G Del Giudice
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils.

Authors:  T Watanabe; M Tada; H Nagai; S Sasaki; M Nakao
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

8.  Comparison of five PCR methods for detection of Helicobacter pylori DNA in gastric tissues.

Authors:  J J Lu; C L Perng; R Y Shyu; C H Chen; Q Lou; S K Chong; C H Lee
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.

Authors:  H M Mitchell; S L Hazell; Y Y Li; P J Hu
Journal:  Am J Gastroenterol       Date:  1996-09       Impact factor: 10.864

10.  Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection.

Authors:  P F Saldinger; N Porta; P Launois; J A Louis; G A Waanders; H Bouzouréne; P Michetti; A L Blum; I E Corthésy-Theulaz
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

View more
  6 in total

1.  Recombinant Helicobacter pylori catalase.

Authors:  Yang Bai; Ya-Li Zhang; Jian-Feng Jin; Ji-De Wang; Zhao-Shan Zhang; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

2.  Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori.

Authors:  Zheng Jiang; Ai-Long Huang; Xiao-Hong Tao; Pi-Long Wang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  Construction of hpaA gene from a clinical isolate of Helicobacter pylori and identification of fusion protein.

Authors:  Ya-Fei Mao; Jie Yan; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

4.  Helicobacter pylori recombinant UreG protein: cloning, expression, and assessment of its seroreactivity.

Authors:  Akbar Khalilpour; Sabariah Osman; Muhammad Hafiznur Yunus; Amutha Santhanam; Nagarajan Vellasamy; Rahmah Noordin
Journal:  BMC Res Notes       Date:  2014-11-18

5.  DNA vaccine containing Flagellin A gene induces significant immune responses against Helicobacter pylori infection: An in vivo study.

Authors:  Hossein Ansari; Maryam Tahmasebi-Birgani; Mahdi Bijanzadeh
Journal:  Iran J Basic Med Sci       Date:  2021-06       Impact factor: 2.699

6.  Preparative SDS-PAGE Electroelution for Rapid Purification of Alkyl Hydroperoxide Reductase from Helicobacter pylori.

Authors:  T Mohammadian; M Doosti; M Paknejad; F Siavoshi; S Massarrat
Journal:  Iran J Public Health       Date:  2010-03-31       Impact factor: 1.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.